{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201909238058/health-care-down-as-rotation-out-of-sector-resumes-health-care-roundup", "downloaded_at": "2019-09-24 00:52:41.773224+00:00", "title": "Health Care Down as Rotation Out of Sector Resumes \u2014 Health Care Roundup", "language": "en", "text": "Health-care companies fell as a rotation out of the sector resumed.\n\nWhile regulatory and litigation fears weigh on traditional insurance and pharmaceutical stocks, the biotech subsector has seen outflows as investors turn against the \"momentum\" stocks that led the bull market for much of the last decade.\n\n\"A perceived lull in U.S.-China trade tensions has eased market fears about an economic downturn, prompting a rebound in bond yields,\" said strategists at money manager BlackRock's Investment Institute, in a note to clients. \"One result: a shift in equity factor leadership. U.S. value has recovered and momentum stumbled.\"\n\nMallinckrodt shares rallied after the specialty drug maker said a treatment for regenerating tissue showed promise in a late stage clinical trial.\n\nWrite to Rob Curran at rob.curran@dowjones.com\n\n(END) Dow Jones Newswires\n\nSeptember 23, 2019 16:46 ET (20:46 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-09-23"}